STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Q-Med (STO:QMED) has obtained registration approval for Restylane® in China. An application for sales approval will be submitted shortly and it is estimated that sales of the product will begin at the end of the second quarter in 2009.
